Unibest 优贝德
← Back to patent-cliff list

马来酸奈拉替尼

Tier C — Watch / trade

Neratinib Maleate · all drugs expiring in 2030 →

辉瑞
Originator
2017
First approval
2030
Expiry (public)
$0.21B ▲
Peak sales
化学药
Type

TargetsHER4、EGFR、HER2

Brand贺俪安、汉奈佳、赫赛佳、Nerlynx、Hernera

Indications (approved)乳腺癌

Regional status

US
批准上市
2017-07-17
EU
批准上市
2018-08-31
China
批准上市
2020-04-27
Japan
无进展
2009-07-09

Synthetic routes & intermediates4 routes

Originator routes × 1Optimised (non-patent) × 3Process routes × 0

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OriginatorRoute 1Steps 3 · Total yield 0.86 g
Synthetic routes & intermediates Route 1
CodeCAS No.Intermediate
NERT-001214476-09-24-chloro-7-ethoxy-6-nitroquinoline-3-carbonitrile
NERT-002848133-87-96-amino-4-chloro-7-ethoxyquinoline-3-carbonitrile
NERT-0031056149-69-9(E)-4-(dimethylamino)but-2-enoyl chloride
NERT-004848133-88-0(E)-N-(4-chloro-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide
NERT-005524955-09-7Available3-chloro-4-(pyridin-2-ylmethoxy)aniline
OptimisedRoute 2Steps 6 · Total yield 154 g
Synthetic routes & intermediates Route 2
CodeCAS No.Intermediate
NERT-005524955-09-7Available3-chloro-4-(pyridin-2-ylmethoxy)aniline
NERT-006619-08-92-chloro-4-nitrophenol
NERT-007586-98-1pyridin-2-ylmethanol
NERT-008179687-79-72-((2-chloro-4-nitrophenoxy)methyl)pyridine
NERT-009848133-76-6AvailableN-(4-chloro-3-cyano-7-ethoxyquinolin-6-yl)acetamide
NERT-010915941-95-6N-(4-((3-chloro-4-(pyridin-2-ylmethoxy)phenyl)amino)-3-cyano-7-ethoxyquinolin-6-yl)acetamide
NERT-011848139-78-6Available6-amino-4-((3-chloro-4-(pyridin-2-ylmethoxy)phenyl)amino)-7-ethoxyquinoline-3-carbonitrile
NERT-0121632473-08-5(E)-4-(dimethylamino)but-2-enoic acid hydrochloride
OptimisedRoute 3Steps 9 · Total yield 15 mg
Synthetic routes & intermediates Route 3
CodeCAS No.Intermediate
NERT-005524955-09-7Available3-chloro-4-(pyridin-2-ylmethoxy)aniline
NERT-013625-35-4(E)-but-2-enoyl chloride
NERT-014927802-54-8methyl 3-amino-4-ethoxybenzoate
NERT-0151403831-68-4(E)-methyl 3-(but-2-enamido)-4-ethoxybenzoate
NERT-0161403831-69-5(E)-methyl 5-(but-2-enamido)-4-ethoxy-2-nitrobenzoate
NERT-0171403831-70-8-
NERT-0182032-34-03,3-diethoxypropanenitrile
NERT-0191403831-73-1methyl 5-((E)-but-2-enamido)-2-((2-cyanovinyl)amino)-4-ethoxybenzoate
NERT-0201403831-74-2(E)-N-(3-cyano-7-ethoxy-4-oxo-1,4-dihydroquinolin-6-yl)but-2-enamide
NERT-0211403831-79-7(E)-N-(4-chloro-3-cyano-7-ethoxyquinolin-6-yl)but-2-enamide
NERT-0221403831-80-0(E)-N-(4-((3-chloro-4-(pyridin-2-ylmethoxy)phenyl)amino)-3-cyano-7-ethoxyquinolin-6-yl)but-2-enamide
NERT-0231257230-74-2(E)-4-bromo-N-(4-((3-chloro-4-(pyridin-2-ylmethoxy)phenyl)amino)-3-cyano-7-ethoxyquinolin-6-yl)but-2-enamide
OptimisedRoute 4Steps 12 · Total yield /
Synthetic routes & intermediates Route 4
CodeCAS No.Intermediate
NERT-008179687-79-72-((2-chloro-4-nitrophenoxy)methyl)pyridine
NERT-009848133-76-6AvailableN-(4-chloro-3-cyano-7-ethoxyquinolin-6-yl)acetamide
NERT-010915941-95-6N-(4-((3-chloro-4-(pyridin-2-ylmethoxy)phenyl)amino)-3-cyano-7-ethoxyquinolin-6-yl)acetamide
NERT-011848139-78-6Available6-amino-4-((3-chloro-4-(pyridin-2-ylmethoxy)phenyl)amino)-7-ethoxyquinoline-3-carbonitrile
NERT-0121632473-08-5(E)-4-(dimethylamino)but-2-enoic acid hydrochloride
NERT-024121-88-02-amino-5-nitrophenol
NERT-02525351-89-7N-(2-hydroxy-4-nitrophenyl)acetamide
NERT-026116496-76-5N-(2-ethoxy-4-nitrophenyl)acetamide
NERT-027848655-78-7N-(4-amino-2-ethoxyphenyl)acetamide
NERT-02894-05-3ethyl (Z)-2-cyano-3-ethoxyacrylate
NERT-029848133-74-4(Z)-ethyl 3-((4-acetamido-3-ethoxyphenyl)amino)-2-cyanoacrylate
NERT-030848133-75-5N-(3-cyano-7-ethoxy-4-hydroxyquinolin-6-yl)acetamide

Frequently asked questions

What are the approved indications of Neratinib Maleate?

Approved indications include: 乳腺癌.

When does the Neratinib Maleate patent expire?

Based on public sources, the Neratinib Maleate patent expires in 2030.

How many synthesis routes are recorded for Neratinib Maleate?

4 synthesis routes are recorded; the shortest is 3 steps with 0.86 g total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy Neratinib Maleate intermediates?

3 intermediate CAS of Neratinib Maleate are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.

How do I get a quote for Neratinib Maleate intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-09-24